Medicare billing address
CMS Medicare provider billing file
601 Ivy Gtwy Ste 1100Cincinnati, OH 45245
CMS public data · NPI 1699768499
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
David R Drosick, MD
Specialty
Credential
MD
NPI
1699768499
Primary source state
OH
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for David R Drosick, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
601 Ivy Gtwy Ste 1100CMS Doctors & Clinicians file
3301 Mercy Health BlvdCMS Doctors & Clinicians file
4777 E Galbraith RdCMS Doctors & Clinicians file
580 Buttermilk PikeIn the 2024 CMS provider billing file, this NPI had 725 Medicare beneficiaries and 120,631 total services. The average beneficiary age was 73, and the average HCC risk score was 1.8.
Total Medicare allowed amount
$2,780,676.43
Total Medicare payment amount
$2,207,756.27
Medicare beneficiaries
725
Total services
120,631
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
71%
CMS beneficiary-panel share
Hypertension
71%
CMS beneficiary-panel share
Ischemic heart disease
31%
CMS beneficiary-panel share
Diabetes
27%
CMS beneficiary-panel share
Mood disorders
27%
CMS beneficiary-panel share
Chronic kidney disease
26%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, nivolumab, 1 mg | 16,160 | $30.35 |
| Injection, pembrolizumab, 1 mg | 14,216 | $56.22 |
| Injection, paclitaxel, 1 mg | 7,820 | $0.10 |
| Injection, fosaprepitant, 1 mg | 6,000 | $0.14 |
| Injection, ferric derisomaltose, 10 mg | 2,800 | $19.90 |
| Injection, dexamethasone sodium phosphate, 1 mg | 1,732 | $0.11 |
| Injection, denosumab, 1 mg | 1,440 | $25.43 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,091 | $7.59 |
| Blood test, comprehensive group of blood chemicals | 956 | $10.33 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 920 | $84.50 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1699768499. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Anastrozole | Anastrozole | 511 | 995 | $6,846.46 |
| 2 | Oxycodone Hcl | Oxycodone Hcl | 239 | 239.4 | $6,191.27 |
| 3 | Eliquis | Apixaban | 175 | 211 | $122,486.21 |
| 4 | Ibrance | Palbociclib | 124 | 124 | $1,920,435.42 |
| 5 | Morphine Sulfate Er | Morphine Sulfate | 101 | 101 | $3,208.93 |
| 6 | Levothyroxine Sodium | Levothyroxine Sodium | 95 | 157 | $514.01 |
| 7 | Ondansetron Hcl | Ondansetron Hcl | 90 | 96 | $14,567.25 |
| 8 | Duloxetine Hcl | Duloxetine Hcl | 83 | 109 | $1,204.12 |
| 9 | Letrozole | Letrozole | 80 | 165.3 | $1,681.89 |
| 10 | Prednisone | Prednisone | 79 | 97 | $411.99 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
West Virginia University School Of Medicine
Graduation year
1985
Group/practice field
Oncology Hematology Care Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.